ABSTRACT
INTRODUCTION
Corrosive esophageal burns, that mostly happen accidentally in children, constitute a serious problem across different age groups and are relatively common in rural areas and developing countries. [1] Corrosive esophageal burns are caused by alkaline substances in 90% of cases and by acidic substances in the remaining 10%. [2] Alkaline substances are easily acces- fibrosis leading to strictures. [3] [4] [5] The aims of the treatment for corrosive esophageal burns are to improve wound healing, prevent perforation, and reduce stricture formation. There is a close connection between the severity of the initial injury and the stricture formation, which is a significant complication of corrosive esophageal burns. Therefore, the initial treatment may play a game-changing role in preventing the development of strictures. [6] [7] [8] Since stricture formation is a consequence of the inflammation and fibrosis that occurs during wound healing, medical treatment should focus on reducing the wound inflammation. [9] Although many agents, including retinoic acid, pentoxifylline, sucralfate, N-acetylcysteine, antibiotics, and steroids have been used in both clinical and experimental studies to prevent the development of strictures, only antibiotics and steroids have gained clinical application. [10] [11] [12] [13] MB was first identified as an antimalarial agent by Ehrlich in 1981, and it has since been used in many different areas of clinical medicine including treatment of refractory distributive shock, renal stones, carbon monoxide poisoning, methemoglobinemia, and encephalopathy for years due to its low toxicity and wide availability. [14, 15] Most recently, MB was described as an effective product for preventing postoperative adhesions as well. Although the mechanism is unknown, the anti-adhesive effect of MB may depend on the reduction of the anti-inflammatory products caused by trauma and antioxidant effects, such as the inhibition of the effect of nitric oxide (NO) and activation of fibrinolytic activity. [16, 17] Based on the literature describing the anti-adhesive effect of MB, we aimed to investigate the effect of MB treatment on corrosive esophageal burns.
MATERIALS AND METHODS

Study Design and Animals
Each experiment was performed based on the National Guidelines for The Use and Care of Laboratory Animals after obtaining the approval of the Animal Ethics Committee of Bulent Ecevit University (number: 2014/12). Twenty-eight male adult Wistar-Albino rats, weighing 250±30 g, were housed individually under constant temperature (21±1 °C) in wire cages with 12-hour light-dark cycles, fed a standard diet, and given water ad libitum. The animals were deprived of food from 12 hours before anesthesia. However, no water restriction was done until 2 hours before anesthesia. No enteral or parenteral antibiotics were administered at any time.
Experimental Model
The experimental corrosive esophageal burns were induced according to the model described by Gehanno et al. [18] in 1981. All the animals were sedated using 80 mg/kg ketamine hydrochloride (KetalarR; Parke-Davis, Istanbul, Turkey) and 20 mg/kg xylazine (RompunR, Bayer, Istanbul, Turkey) intramuscularly. In this study, a 1.5 cm distal esophageal segment was used to administer the burns. Following a median laparotomy, a five Fr catheter was inserted through the mouth and placed into the distal esophagus. To prevent the escape of the solution directly into the stomach or into the respiratory tract by aspiration, the cardio-esophageal junction and proximal esophagus were tied with 2/0 silk. A solution of 0.1 mL of 37.5% sodium hydroxide (NaOH) was administered for 90 seconds and then aspirated. Next, the burned segments were washed using distilled water for 30 seconds. After cutting the sutures, the gastric insertion sites were also repaired. Following the closure of the laparotomy, 10 mL of 0.9% saline was administered intraperitoneally, and the rats were made to fast for the next 24 hours. The treatment of the study groups started on the first postoperative day. The rats were observed under standard laboratory conditions by feeding standard food and water ad libitum during the treatment period. No rats died during the experiment.
Experimental Groups
Twenty-eight rats were randomly divided into four groups (7 rats in each group):
Group 1 (Sham): A corrosive esophageal burn was not created after laparotomy. A 0.1 mL dose of saline was administered intraperitoneally to each rat as a single daily dose for ten days.
Group 2 (Control):
A corrosive esophageal burn was created after laparotomy. A 0.1 mL dose of saline was administered intraperitoneally to each rat as a single daily dose without any treatment for ten days and the esophageal lumen was washed with a 0.1 mL dose of saline.
Group 3 (Topical Treatment):
A corrosive esophageal burn was created after laparotomy. After washing the esophageal lumen with saline, a 0.1 mL dose of 1% MB was administered topically to the esophageal lumen. The rats were placed in the reverse Trendelenburg position for 30 minutes to provide sufficient mucosal contact with the drug. Later, a 0.1 mL dose of saline was administered intraperitoneally to each rat as a single daily dose for ten days.
Group 4 (Topical+Systemic Treatment):
A corrosive esophageal burn was created after laparotomy. After washing the esophageal lumen with saline, a 0.1 mL dose of 1% MB was administered topically to the esophageal lumen. The rats were placed in the reverse Trendelenburg position for 30 minutes to provide sufficient mucosal contact with the drug. Later, a 0.1 mL dose of 1% MB was administered intraperitoneally to each rat as a single daily dose for ten days.
Histopathological Evaluation
One well-experienced pathologist who was blinded to the study design evaluated each specimen. For this evaluation, 2 cm distal esophagus sections were taken. A solution of 10% neutral formaldehyde was used to fix the esophageal tissue samples and followed by the paraffin embedding technique. Tissue samples of 4 μm thickness were stained using hematoxylin-eosin (H&E) and then analyzed under a light microscope (Olympus BX53, Tokyo, Japan).
Stenosis index (SI) was chosen to assess the degree of stenosis of the esophageal lumen in our study. For this evaluation, esophageal wall thickness was measured in two different areas from the mucosal surface to the connective tissue outside the muscularis propria using a millimetric ocular microscope and the average of the two measurements was calculated (A0 = [A1+A2]/2). The lumen diameters were also measured in two different areas along a straight line, and the average of the two measurements was obtained (B0 = [B1+B2]/2). The SI was calculated as follows: SI = (wall thickness [A0])/lumen diameter [B0]). [19] The histopathologic damage score (HDS) was used to determine the degree of damage and collagen accumulation in the esophageal wall. The tissues were scored on a scale in three different categories for a total score of 0-5 (Table 1) . [20] For this evaluation, the sections obtained from the paraffin-embedded tissue were stained with Masson's trichrome in order to evaluate changes in the connective tissue.
Biochemical Analysis
The spectrophotometric method was used to detect tissue hydroxyproline concentrations and the results were given as micrograms per milligram of tissue. [21] The serum TNF-α levels were assessed using the Rat TNF-α ELISA kit (Eastbiopharm, Hangzhou) as described in the instruction book. First, the samples, standards, and streptavidin-HRP were added to the well. The antibodies were labeled with an enzyme and the plate was incubated for 60 minutes at 37ºC. The plate was washed five times and chromogen solutions were added. The plate was incubated for 10 minutes at 37ºC and the stop solution was added into the wells. The optical density (OD) was measured under 450 nm wavelengths with a microplate reader. According to standards concentration, the corresponding OD values were calculated using the standard curve linear regression equation to calculate the corresponding sample's concentration. 
Statistical Analysis
RESULTS
The comparison of the levels of hydroxyproline and TNF-α among the groups are summarized in Table 2 . The levels of hydroxyproline were significantly lower in the treatment groups than in group 2 (p=0.005 for group 3 and p=0.009 for group 4). The levels of TNF-α were lower in the treatment groups than in group 2, however, these differences were not statistically significant (p=0.413 for group 3 and p=0.444 for group 4).
The comparison between the esophageal stenosis assessments among the groups is given in Table 3 . There were no differences between the groups in terms of lumen diameters. The control group did not show a narrowing of the lumen diameter but showed an increase in wall thickness. The wall thicknesses in the treatment group were lower than in group 2; wall thickness in the group that systemically received MB was closer to the sham group; and there was a difference in wall thickness between group 4 and group 2 (p=0.023), but there was no difference between group 3 and group 2 (p=0.687). According to the SI, there were differences between the treatment group and group 2 (p=0.016 for group 3 and p=0.015 group 4).
The comparisons of the histopathological evaluations between groups are summarized in Table 3 and Fig. 1 . HDS was chosen as the method of evaluation in our study and was used to evaluate the increase in collagen deposition in the submucosal area and tunica muscularis and the destruction of muscularis mucosa. Sham group showed a normal histologic state and lumen diameter. Other groups showed variable rates of inflammatory cells in the esophagus wall with characterized reactions. There were no differences between the groups in the increase of submucosal collagen (p=0.210). Damage to the muscularis mucosa was significantly lower in group 4 than group 2 (p=0.043 and p=0.026, respectively), but there was no difference between group 2 and group 3. The total HDS was significantly lower in group 4 than in group 2 (p=0.019) (Fig. 1) .
DISCUSSION
There are many experimental and clinical investigations regarding the treatment of esophageal burns in the literature. However, there are no effective and safe agents to administer the said treatment. Although MB is used effectively in many other areas of medicine, there are almost no studies on its effects on corrosive esophageal burns. This study revealed the protective and anti-inflammatory effects of MB on esophageal burns.
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Şen Tanrıkulu et al. The protective and anti-inflammatory effect of MB in corrosive esophageal burns Ingestion of caustic substances is a serious problem that causes corrosive esophagitis in the acute necrotic phase and stricture formation in the long-term. Therefore, the key to reducing these complications is a very good understanding of the pathophysiology. The level of damage varies based on the type of tissue affected, the amount of ingested substance, the period of contact, the type of agent (acid and alkali), and the physical structure (solid or liquid) of the caustic substance. [4] Alkaline substances cause liquefaction necrosis, while acidic substances cause coagulation necrosis that is mostly limited to the mucosa. [22] The acute necrotic phase occurs during the first 1-4 days following the injury and is characterized by decreased perfusion of the tissue, increased lipid peroxidation, hydrolysis, and reactive oxygen radicals and the beginning of the inflammatory reaction. Following the subacute phase, scar formation related to fibroblast proliferation and stricture formation related to collagen accumulation may occur. [12, 22] The medical treatment needs to reduce the inflammation because the degree of the acute inflammatory reaction plays the most important role in stricture formation. [23] The current management protocol for corrosive esophagitis is still limited to antibiotics, steroids, and neutralization in the acute phase, although there are many other treatment methods that vary according to the phase and the severity of the damage. [9] To reduce inflammation and collagen synthesis and to prevent fibroplasia and stricture formation, numerous studies have been performed to evaluate the medical efficiency of antioxidant and anti-inflammatory agents such as sucralfate, palifermin, dimethyl sulfoxide, prednisolone, retinoic acid, zinc, trimetazidine, and pentoxifylline. [9] [10] [11] [12] [13] 22, 23] Despite the decreased stricture formation demonstrated in these studies, the rate of stricture formation is still 70-100% in high-grade corrosive esophagitis. [9] MB, a nontoxic and safe dye, has both anti-adhesive and antiinflammatory properties. Although the main mechanism of action of MB is unknown, the primary effect of MB inhibits guanylate cyclase by targeting NO. The anti-adhesive effects of MB may depend on the reduction of the anti-inflammatory products caused by trauma and antioxidant effects such as inhibition of the effect of NO and the activation of the fibrinolytic activity. [17, 24] In addition, MB shows immunomodulatory effect by the expression of adhesion molecules on endothelial cells. MB reduced TNF production by 50% and inhibited the systemic and local inflammation. [25] The main effect of MB in inflammation has not been fully clarified as of today and its mechanism should be analyzed further. Besides the anti-inflammatory effects of MB, it has antioxidant effects as well. In contrast to classic antioxidants like vitamin E, MB has a direct inhibitory effect on endogenous NADPH. [26] On reviewing the literature, several studies can be found on the effect of MB. One of them was conducted by Kilincaslan et al., [27] who found that MB applied locally might reduce the tissue damage in corrosive esophagitis because of its antioxidant effects. In their studies on adhesions, Kalaycı et al. [17] and Dinc et al. [16] found that while MB may prevent peritoneal adhesions, it could wound healing could be impaired.
In a randomized retrospective study conducted by Gümürdülü et al., [9] it was found that the prevalence of stricture formation could be reduced with sucralfate treatment. Howell et al. [28] found that treatment of corrosive esophagitis with steroids decreased the frequency of stricture formation. In their study comparing beta-aminopropionitrile (BAPN) and prednisolone, Aciksari et al. [13] found that BAPN was able to decrease the development of stenosis and tissue damage better than prednisolone. Şen Tanrıkulu et al. [29] found that garlic oil is an effective agent in promoting the regression of esophageal stenosis and tissue damage caused by corrosive burns. In another study, [23] investigators found that dimethyl sulfoxide may decrease the severity of tissue damage. In addition to inflammation, oxidative stress has a key role in increased tissue damage. It was shown that reactive oxygen radicals increased during the early phase of esophageal burns and that NaOH treatment increased lipid peroxidation. [19, 30] In corrosive esophageal burns, while SI and HDS are the most important indicators of esophagus damage, the levels of hydroxyproline are an indicator of collagen accumulation. These indicators are used to demonstrate the esophageal stricture and to evaluate the efficacy of therapeutic agents. [11] In our study, we examined SI and HDS to evaluate esophageal damage, levels of hydroxyproline to evaluate collagen accumulation, and levels of TNF-α to evaluate the anti-inflammatory effect. We found that the levels of hydroxyproline were lower in the treatment groups than in the control group. Although the levels of TNF-α were lower in the treatment groups than in group 2, the differences were not significant. In addition, we found that there were differences in the SI results between treatments groups and the control group. The total HDS was significantly lower in group 4 than the control group (p=0.019).
Unfortunately, the current results hardly suggest that we use MB in a clinical setting. In this rat model, we applied a constant quantity of MB to the esophageal lumen via a catheter. In reality, the clinical use of MB is poorly understood. MB is mostly used as 10 mg/ml in the form of an ampoule as a pharmaceutical treatment for several diseases such as methemoglobinemia. [31] In the daily clinical routine, MB doses of up to 7 mg/ kg have been used in humans in case of shock. [32] The highest acceptable dose of MB is 9 mg/kg. [33] Although the optimal dose of this dye is not known, based on the present study results we concluded that a volume of 1% of MB may reduce the level of stenosis. Finally, the ingestion of commercial bulb forms containing methylene blue per orally can be suggested after corrosive ingestion.
Conclusions
In this study, we found that MB administered topically and/ or systemically was an effective agent to treat tissue damage caused by corrosive burns and to prevent esophageal stenosis. This beneficial effect was more pronounced with systemic treatment. However, a significant anti-inflammatory effect of MB was not detected. We believe that the use of MB during the initial emergency clinic treatment of patients with corrosive esophageal burns could reduce complications such as stenosis and strictures. To assess the medical application of MB, further comprehensive clinical studies are required.
